Bubble Knock Out Acne Spot Treatment

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the treatment of acne. It helps to clear acne blemishes, acne pimples, blackheads, and whiteheads, facilitating the healing of the skin.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended administration involves applying a thin layer to the entire affected area. This application should occur one to three times daily, depending on the patient's needs and the physician's guidance.

Initially, it is advisable to start with one application per day. Based on the patient's response and as directed by a healthcare provider, the frequency may be gradually increased to two or three times daily.

In cases where the patient experiences bothersome dryness or peeling, it is recommended to reduce the frequency of application to once a day or every other day to mitigate these effects.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients may experience skin irritation or dryness, particularly when the product is used concurrently with other topical acne treatments. In such cases, it is recommended to limit the use of acne treatments to one at a time. Additionally, if irritation occurs, patients should reduce the frequency of application to every other day to mitigate adverse effects. Monitoring for signs of skin irritation is advised to ensure patient safety and comfort.

Side Effects

For external use only. Patients may experience skin irritation or dryness, particularly when this product is used in conjunction with other topical acne medications. In such cases, it is advised to limit the use of acne treatments to one at a time and to reduce the frequency of application to every other day to mitigate these effects.

In the event of accidental ingestion, it is crucial for patients to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

Skin irritation or dryness may occur when this medication is used concurrently with other topical acne treatments. To mitigate these effects, it is advised to limit the use of acne treatments to one at a time. In cases where irritation or dryness develops, dosage adjustments should be considered, such as reducing the frequency of application to every other day. Monitoring for skin reactions is recommended to ensure patient comfort and treatment efficacy.

Packaging & NDC

Below are the non-prescription pack sizes of Bubble Knock Out Acne Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. Should any bothersome dryness or peeling occur, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. The use of salicylic acid during pregnancy may pose significant risks, and it is advised that pregnant patients consult a healthcare provider before use. Dosage adjustments may be necessary for pregnant individuals, and it is recommended to avoid use unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed.

Additionally, patients should be informed that skin irritation or dryness may occur, particularly when used in conjunction with other topical acne treatments. In such cases, it is recommended that patients use only one acne treatment at a time and consider reducing the frequency of application to every other day to minimize adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the recommended temperature range to maintain its integrity and efficacy. Storage should be avoided at extreme temperatures, specifically below 40°F and above 100°F. Proper container requirements must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation. Special handling needs should be observed to ensure the product remains stable and effective throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bubble Knock Out Acne Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)